MPD: Phenotype measures mapped to VT:0010527, associative learning trait

An error occurred on this page.
These results could be incomplete or invalid. Staff have been notified.

Phenotype measures in CSNA03 associated with ontology term
VT:0010527 'associative learning trait'

Navigate ontologies

All measures in this list are mapped to the ontology descendants of VT:0010527. None are mapped to VT:0010527 directly.

VT:0010531 operant conditioning behavior trait

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
CSNA03:449	CSNA03	operant conditioning chamber	cocaine	number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), founders [n] acquisition_in 110188	inbred w/CC8	7	both	4-25wks	N=10	2018

CSNA03:450	CSNA03	operant conditioning chamber	cocaine	number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), CC [n] acquisition_cc 110390	CC w/par	53	both	4-25wks	N=4	2018

CSNA03:451	CSNA03	operant conditioning chamber	cocaine	number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), DO [n] acquisition_do 110261	DO population w/par	8	both	4-25wks	N=48	2018

CSNA03:452	CSNA03	operant conditioning chamber	cocaine	dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders [n] infusions_in 110189 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	inbred w/CC8	8	both	4-25wks	N=14	2018

CSNA03:461	CSNA03	operant conditioning chamber	cocaine	dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC [n] infusions_cc 110391 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	CC w/par	57	both	4-25wks	N=6	2018

CSNA03:470	CSNA03	operant conditioning chamber	cocaine	dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO [n] infusions_do 110262 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	DO population w/par	9	both	4-25wks	N=73	2018

CSNA03:479	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), founders [n] extinction_active_in 110198 session: 1 2 3 4 5 6 7 8 9	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:488	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), CC [n] extinction_active_cc 110400 session: 1 2 3 4 5 6 7 8 9	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:497	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), DO [n] extinction_active_do 110271 session: 1 2 3 4 5 6 7 8 9	DO population w/par	8	both	4-25wks	N=39	2018

CSNA03:506	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), founders [n] extinction_inactive_in 110207 session: 1 2 3 4 5 6 7 8 9	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:515	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), CC [n] extinction_inactive_cc 110409 session: 1 2 3 4 5 6 7 8 9	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:524	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), DO [n] extinction_inactive_do 110280 session: 1 2 3 4 5 6 7 8 9	DO population w/par	8	both	4-25wks	N=39	2018

CSNA03:533	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), founders [n] reinstatement_active_in 110216 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:535	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), CC [n] reinstatement_active_cc 110418 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:537	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), DO [n] reinstatement_active_do 110289 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:540	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), founders [n] reinstatement_inactive_in 110218 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:542	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), CC [n] reinstatement_inactive_cc 110420 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:544	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), DO [n] reinstatement_inactive_do 110292 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:547	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), founders [n] reinstatement_inf_in 110220 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:549	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), CC [n] reinstatement_inf_cc 110422 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:551	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), DO [n] reinstatement_inf_do 110295 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:554	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), founders [n] days_criteria_in_JAX 110457 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:556	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), CC [n] days_criteria_cc_JAX 110487 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:558	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), DO [n] days_criteria_do_JAX 110517 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:560	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), founders [n] trials_in_JAX 110459 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:562	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), CC [n] trials_cc_JAX 110489 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:564	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), DO [n] trials_do_JAX 110519 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:566	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_JAX 113850	inbred w/CC8	8	both		N=7	2021

CSNA03:567	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_JAX 113851	CC w/par	52	both		N=3	2021

CSNA03:568	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), DO [n] diff_trials_rev_acq_do_JAX 113853	DO population w/par	9	both		N=28	2021

CSNA03:569	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_JAX 110461 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:571	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_JAX 110491 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:573	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO [n] correct_do_JAX 110521 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:575	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_JAX 110463 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:577	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_JAX 110493 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:579	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO [n] omit_do_JAX 110523 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:581	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_JAX 110465 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:583	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_JAX 110495 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:585	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), DO [%] pct_correct_do_JAX 110525 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:587	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_JAX 110467 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:589	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_JAX 110497 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:591	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), DO [%] pct_omit_do_JAX 110527 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:593	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), founders [min] total_time_in_JAX 110469 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:595	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), CC [min] total_time_cc_JAX 110499 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:597	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), DO [min] total_time_do_JAX 110529 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:605	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_JAX 110473 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:607	CSNA03	operant conditioning chamber	(none)	mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_JAX 110503 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:609	CSNA03	operant conditioning chamber	(none)	mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO [centiseconds/n] trial_init_latency_do_JAX 110533 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:617	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), founders [centiseconds/n] reward_time_in_JAX 110477 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:619	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), CC [centiseconds/n] reward_time_cc_JAX 110507 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:621	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), DO [centiseconds/n] reward_time_do_JAX 110537 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:623	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_left_in_JAX 110479 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:625	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_left_cc_JAX 110509 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:627	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_left_do_JAX 110539 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:629	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_right_in_JAX 110481 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:631	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_right_cc_JAX 110511 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:633	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_right_do_JAX 110541 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:635	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_JAX 110483 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:637	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_JAX 110513 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:639	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_correct_do_JAX 110543 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:641	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_JAX 110485 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:643	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_JAX 110515 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:645	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_incorrect_do_JAX 110545 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:647	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), founders [n] trials_in_Binghamton 112873 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:649	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), CC [n] trials_cc_Binghamton 112891 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:651	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_Binghamton 113852	inbred w/CC8	8	both		N=5	2021

CSNA03:652	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_Binghamton 113854	CC w/par	18	both		N=4	2021

CSNA03:653	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_Binghamton 112875 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:655	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_Binghamton 112893 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:657	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_Binghamton 112877 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:659	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_Binghamton 112895 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:661	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_Binghamton 112879 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:663	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_Binghamton 112897 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:665	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_Binghamton 112881 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:667	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_Binghamton 112899 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:669	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), founders [min] total_time_in_Binghamton 112883 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:671	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), CC [min] total_time_cc_Binghamton 112901 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:673	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_Binghamton 112885 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:675	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_Binghamton 112903 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:677	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_Binghamton 112887 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:679	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_Binghamton 112905 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:681	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_Binghamton 112889 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:683	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_Binghamton 112907 acquisition reversal	CC w/par	18	both		N=4	2021

An error occurred on this page.These results could be incomplete or invalid. Staff have been notified.

Filter Table Results

An error occurred on this page.
These results could be incomplete or invalid. Staff have been notified.